GARDskin approved by OECD

THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay

Get a quote

Sensitization Testing with GARD®

Regulatory Toxicity Testing

Biological Evaluation of Medical Devices

The GARD® technology: An holistic approach

Learn more about the improved accuracy and human relevance

SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.

GLP Compliant Laboratory

READ MORE

Meet Us.

Webinar: Latest GARD® innovation and research in in vitro skin and respiratory sensitization

October 18 @ 16:00 - 17:00

ACT 2023 Annual Meeting

November 12 - November 15Orlando, Florida
EVENT CALENDAR

Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
28 Sep, 2023
News
IR
English
Corporate Information
Sales
Order
SenzaGen continues to collaborate with RIFM in non-animal photosensitization and fragrance safety – receives a new grant worth SEK 1.6m
24 Aug, 2023
News
IR
English
Regulatory
MAR
Report
Interim
Q2
SenzaGen’s 2023 Half-Year Report: Continued growth, improved gross margin and lower loss
07 Jul, 2023
News
IR
English
Corporate Information
Other Corporate Information
SenzaGen strengthens its market presence with expanded distribution channels
Next

News Posts

Subscribe


Prenumerera